Related Experiment Video
Updated: Nov 17, 2025

12:40
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
15.1K
EDA-ID: a Severe Clinical Presentation Associated with a New IKBKG Mutation
Coline Bret Puvilland1, Bertrand Boisson2,3,4, Mathieu Fusaro2,5
1Department of Hematology, Institute of Pediatric Hematology and Oncology (IHOPe), and University Claude Bernard, 1 place du Pr Joseph Renault - 69008, Lyon, France. coline.puvilland@free.fr.
Journal of Clinical Immunology
|February 18, 2021
Abstract
No abstract available in PubMed .
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
316
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
316
Endocarditis II: Clinical Features of Infective Endocarditis
146
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
146
Acute Kidney Injury III: Clinical Manifestations
423
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
423
NF-κB-dependent Signaling Pathway
8.6K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
8.6K

